Skip to content
Clinical Trials – home

Crohn's disease Diagnostics

55 / 94 trials open to patients25 countries

In short

Diagnosing Crohn's disease involves a careful combination of medical history, physical examination, laboratory tests, and imaging procedures that help doctors understand where inflammation is occurring and how severe it has become.

Key points

  • Seek medical attention if you have persistent diarrhea, abdominal pain, weight loss, or bloody stools, as early diagnosis can prevent complications.
  • Diagnosing Crohn's disease requires multiple tests, including medical history, physical exam, blood tests, stool tests, colonoscopy, and imaging studies.
  • Colonoscopy with biopsy is one of the most valuable procedures because it allows doctors to see inflammation directly and take tissue samples for analysis.
  • Granulomas found in biopsies are highly suggestive of Crohn's disease, but they are only present in about half of patients.
  • Imaging tests like CT enterography and MRI help identify disease in parts of the digestive tract that cannot be reached by endoscopy.
  • Clinical trial qualification often requires confirming your diagnosis through colonoscopy, checking inflammation levels, and ruling out infections.
  • Crohn's disease can affect any part of the digestive tract, and doctors tailor diagnostic testing to identify which areas are involved in your case.
  • With proper diagnosis and treatment, most people with Crohn's disease can lead active, fulfilling lives, though the condition is lifelong and requires ongoing management.

Introduction: When to Seek Diagnostic Testing

If you experience persistent symptoms such as chronic diarrhea, abdominal pain and cramping, weight loss, or bloody stools, it is important to seek medical attention. These warning signs may point to Crohn's disease, a chronic inflammatory condition affecting the digestive tract. Early diagnosis is crucial because it allows your healthcare team to start treatment before serious complications develop.

People who should consider diagnostic testing include those with ongoing digestive symptoms that do not improve with standard treatments, individuals with a family history of inflammatory bowel disease, and anyone experiencing fever, fatigue, or mouth sores alongside gastrointestinal issues. Children and teenagers who show signs of growth delays or failure to grow properly should also be evaluated, as Crohn's can affect development.

Because Crohn's disease can present subtly at first, some people may not realize they need testing until symptoms worsen. Diagnostic and treatment delays are not uncommon, especially when there is no clear family history or when symptoms mimic other conditions. This is why understanding when to seek help is so important.

Classic Diagnostic Methods

Diagnosing Crohn's disease requires multiple steps because no single test can confirm the condition. Your healthcare provider will likely begin with a detailed medical history, asking about your symptoms, when they started, how often they occur, and whether you have a family history of inflammatory bowel disease. A physical examination follows, during which your doctor checks for bloating in your abdomen, listens to sounds inside using a stethoscope (a medical tool for listening to body sounds), taps on your abdomen to check for tenderness, and examines whether your liver or spleen feels abnormal or enlarged.

Blood Tests

Blood tests are often among the first diagnostic tools used. They can reveal signs of infection, check for anemia (a condition where you have fewer red blood cells than normal), measure levels of inflammation in your body, and assess your liver function. Blood tests can also screen for inactive infections such as tuberculosis, which is important before starting certain treatments. Additionally, they can check for immunity against specific infections.

Stool Tests

Stool samples help rule out other causes of your symptoms. They can detect blood in your stool, identify infection-causing bacteria or parasites, and look for markers of inflammation such as calprotectin (a protein released during inflammation). These tests are important because some symptoms of Crohn's disease can be similar to those caused by infections or other digestive conditions.

Colonoscopy

A colonoscopy is one of the most valuable procedures for diagnosing Crohn's disease. During this test, a doctor uses a thin, flexible tube with a tiny camera on the end to visually examine the entire colon and the very end of the small intestine, called the ileum. The camera allows the doctor to see inflammation, ulcers, or other abnormalities directly. During the procedure, small tissue samples, called biopsies, may be taken for laboratory analysis. These samples can reveal clusters of inflammatory cells called granulomas, which suggest Crohn's disease, although not all patients have them.

Upper Gastrointestinal Endoscopy

An upper GI endoscopy is a procedure where your provider uses a scope to look inside your mouth, esophagus, stomach, and the beginning of your small intestine. This test is helpful if your doctor suspects Crohn's disease affects the upper parts of your digestive tract, which can happen in some cases. Like a colonoscopy, biopsies can be taken during this procedure.

Imaging Tests

Imaging tests create pictures of the inside of your body and help doctors see areas that cannot be reached by endoscopy. Common imaging tests for Crohn's disease include:

  • CT scan (computed tomography scan): A special X-ray technique that provides detailed images of the entire bowel and tissues outside the bowel. A specific type called CT enterography involves drinking a liquid contrast material and receiving intravenous contrast to produce better images of the small intestine.
  • MRI (magnetic resonance imaging): This test uses magnets and radio waves instead of radiation to create detailed images of soft tissues, including the bowel and surrounding structures.
  • Upper GI series: This test uses a special liquid called barium and X-rays. Drinking the barium makes your upper digestive tract more visible on X-rays, allowing doctors to see abnormalities.

Distinguishing Crohn's Disease from Other Conditions

Crohn's disease must be distinguished from other conditions that cause similar symptoms. These include ulcerative colitis (another type of inflammatory bowel disease), irritable bowel syndrome (a disorder that affects bowel habits but does not cause inflammation), celiac disease (an immune reaction to gluten), infections, and even certain medications that can irritate the digestive tract. Your doctor will use a combination of the tests described above, along with your symptom pattern and biopsy results, to make an accurate diagnosis.

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or strategies for managing Crohn's disease. If you are considering participating in a clinical trial, you will need to undergo specific diagnostic tests to determine if you qualify. These tests help researchers ensure that participants meet the study's criteria and that the trial results will be meaningful and safe.

Standard criteria for enrolling in clinical trials often include confirming the diagnosis of Crohn's disease through colonoscopy and biopsy. Blood tests are used to check your overall health, measure inflammation levels, and ensure your liver and kidney function are adequate. Stool tests may be required to rule out active infections that could interfere with the study. Imaging tests such as CT or MRI scans help determine the extent and location of disease, which is important because some trials focus on specific disease patterns, such as those affecting the small intestine versus the colon.

In some cases, researchers may use specialized tests to measure disease activity more precisely. For example, certain blood markers of inflammation or stool markers like calprotectin may be monitored throughout the trial. Endoscopy with biopsy may be repeated at different points during the trial to see how well the treatment is working.

Clinical trial qualification also involves reviewing your medical history, current medications, and any previous treatments you have tried. Some trials are designed for people who have not responded well to standard therapies, while others may focus on newly diagnosed patients. Your healthcare provider can help you understand which trials you might be eligible for and what additional testing may be needed.

Prognosis and Survival Rate

Prognosis

Crohn's disease is a lifelong condition that cannot be cured, but most people can lead active, fulfilling lives with proper treatment. The disease typically alternates between periods of remission, when symptoms are minimal or absent, and flare-ups, when symptoms return or worsen. Almost everyone with Crohn's disease will experience a flare at some point, but the goal of treatment is to maximize the time spent in remission and minimize the severity of flares.

The prognosis depends on several factors, including the location and pattern of disease, how early treatment begins, and how well you respond to medications. About 19% of patients present with complications such as strictures or fistulas within 90 days of diagnosis, and about half of all patients experience an intestinal complication within 20 years of diagnosis. Disease affecting the upper gastrointestinal tract, ileum, or both the ileum and colon tends to have a greater risk of strictures and fistulas compared to disease limited to the colon.

Between 30% and 55% of people with Crohn's disease will require surgery within 10 years after diagnosis. Surgery does not cure the disease, but it can treat complications and improve symptoms. Even after surgery, the disease may recur, so ongoing monitoring and treatment are important.

There is an increased risk of colorectal cancer in patients with Crohn's disease affecting the colon, particularly when the disease has been active for many years. The risk is similar to that seen in ulcerative colitis when the extent and duration of disease are the same. Regular monitoring with colonoscopy is recommended to detect early signs of cancer.

Survival rate

Crohn's disease is associated with a slightly increased risk of death compared to the general population, but the overall survival rate is quite good, especially with modern treatments. The disease itself is rarely fatal, but complications such as severe infections, toxic colitis, or extensive surgery can pose serious risks if not managed promptly. Most people with Crohn's disease can expect a near-normal lifespan with appropriate medical care and monitoring.

Did you know?

  1. Crohn's disease can skip areas of the digestive tract, leaving sections of healthy tissue between inflamed patches, which is why it's sometimes called "regional enteritis."
  2. Granulomas, which are clusters of inflammatory cells, are considered highly suggestive of Crohn's disease when found in biopsies, but they only appear in about half of patients.
  3. Although Crohn's disease is diagnosed between ages 20 and 29 most commonly, it can show up at any stage of life, including in children and older adults.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Crohn's disease

Recruiting trials first

See all 94 trials →
Quick filters

94 clinical trials in this condition

Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Sar442970
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Ro7790121
  • Sponsor:F. Hoffmann-La Roche AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC
See all 94 trials →filters applied: condition = Crohn's disease

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).